Virta Health claims to reverse Type 2 diabetes without medication or surgery. That sounds like a late-night infomercial, but the company has peer-reviewed clinical evidence showing 60% of patients reverse their diabetes through a medically supervised ketogenic diet. In a country spending $327 billion annually on diabetes, a company that can actually fix the disease instead of just managing it is either revolutionary or too good to be true. The clinical data says revolutionary.
Founded
2014
HQ
San Francisco, USA
Total Raised
$247 million
Founder
Sami Inkinen, Stephen Phinney, Jeff Volek
Status
Private
Website
www.virtahealth.comTHE ORIGIN STORY
Sami Inkinen was an Ironman triathlete and co-founder of Trulia (sold to Zillow for $3.5 billion) who was diagnosed as pre-diabetic despite being one of the fittest people on Earth. His doctors told him it was genetic and he would need medication for life.
He refused to accept that. Inkinen connected with Dr.
Stephen Phinney and Dr. Jeff Volek, researchers who had spent decades studying nutritional ketosis and its effects on metabolic disease.
Together they founded Virta Health in 2014 to deliver their clinical approach — sustained nutritional ketosis with continuous remote medical supervision — as a scalable digital health product.
WHAT THEY ACTUALLY DO
B2B2C model. Virta sells to employers, health plans, and government payers.
These organizations pay Virta to treat their members with Type 2 diabetes. Virta charges an annual per-member fee.
The value proposition for payers is clear: Virta's treatment costs a fraction of ongoing diabetes medication and reduces long-term complications. Revenue scales with the number of enrolled patients.
THE PRODUCTS
Virta Treatment (medically supervised nutritional ketosis). Continuous remote monitoring (biomarkers, blood glucose, ketones).
Physician-led care teams. Health coaching (behavioral support).
Employer and health plan integration.
HOW THEY GREW
Clinical evidence as the growth engine. Virta invested heavily in peer-reviewed clinical trials showing that 60% of patients reversed their Type 2 diabetes after one year, with sustained results at two and five years.
This evidence convinced large employers and health plans to offer Virta as a benefit. The company also targeted the VA (Veterans Affairs) system, which has a massive diabetes burden.
THE HARD PART
Scaling clinical care is hard. Virta's model requires physicians, health coaches, and continuous remote monitoring for every patient.
Unlike pure software businesses, Virta has a significant labor component. Competition from other digital diabetes management companies (Omada Health, Livongo/Teladoc) that focus on management rather than reversal.
MONEY TRAIL
Seed
2015 · Led by Venrock
$7M raised
Series A
2017 · Led by Venrock
$37M raised
Series B
2018 · Led by Various
$45M raised
Series C
2020 · Led by Venrock
$65M raised
Series D
2022 · Led by Various
$93M raised
WHO BACKED THEM
Backed by Venrock, Caffeinated Capital, and various healthcare investors. Venrock led the Series C.
The company has also received endorsements from high-profile health and fitness advocates.
Related Profiles
Head-to-Head
Compare Virta Health vs another company.